Amf Tjanstepension Ab Biogen Inc. Transaction History

Amf Tjanstepension Ab

$13.5 Billion
Q3 2024

A detailed history of Amf Tjanstepension Ab transactions in Biogen Inc. stock. As of the latest transaction made, Amf Tjanstepension Ab holds 63,933 shares of BIIB stock, worth $11.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

63,933

Previous 63,933 -0.0%

Holding current value

$11.1 Million

Previous $12.4 Million -0.0%

% of portfolio

0.09%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$190.52 - $236.72 $3.83 Million - $4.75 Million	20,084 Added 45.8%	63,933 $14.8 Million
Q2 2023 Jul 05, 2023	SELL	$275.25 - $318.06 $494,349 - $571,235	-1,796 Reduced 3.93%	43,849 $12.5 Million
Q3 2022 Oct 26, 2022	SELL	$194.69 - $268.46 $4.84 Million - $6.67 Million	-24,854 Reduced 35.25%	45,645 $12.2 Million
Q2 2022 Jul 26, 2022	SELL	$187.54 - $223.02 $6.21 Million - $7.39 Million	-33,134 Reduced 31.97%	70,499 $14.4 Million
Q1 2022 May 05, 2022	SELL	$193.77 - $244.14 $166,448 - $209,716	-859 Reduced 0.82%	103,633 $21.8 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $2.06 Million - $2.65 Million	9,209 Added 9.66%	104,492 $25.1 Million
Q3 2021 Nov 03, 2021	BUY	$282.99 - $369.05 $3.72 Million - $4.85 Million	13,131 Added 15.98%	95,283 $27 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $4.82 Million - $7.72 Million	-18,612 Reduced 18.47%	82,152 $28.4 Million
Q4 2020 Feb 02, 2021	BUY	$236.26 - $355.63 $4.41 Million - $6.64 Million	18,682 Added 22.76%	100,764 $24.7 Million
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $84,726 - $97,827	-320 Reduced 0.39%	82,082 $23.3 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $2.05 Million - $2.72 Million	7,936 Added 10.66%	82,402 $22 Million
Q1 2020 Apr 14, 2020	SELL	$268.85 - $341.04 $14.7 Million - $18.6 Million	-54,495 Reduced 42.26%	74,466 $23.6 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $2.83 Million - $3.91 Million	-12,846 Reduced 9.06%	128,961 $38.3 Million
Q3 2019 Oct 29, 2019	BUY	$217.44 - $243.88 $3.48 Million - $3.9 Million	15,988 Added 12.71%	141,807 $33 Million
Q2 2019 Jul 11, 2019	BUY	$219.29 - $241.72 $6.11 Million - $6.74 Million	27,879 Added 28.47%	125,819 $29.4 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $16.1 Million - $25.2 Million	-74,344 Reduced 43.15%	97,940 $23.2 Million
Q4 2018 Jan 30, 2019	SELL	$278.5 - $352.75 $6.37 Million - $8.07 Million	-22,880 Reduced 11.72%	172,284 $51.8 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $6.94 Million - $9.08 Million	-23,655 Reduced 10.81%	195,164 $69 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $4.05 Million - $4.83 Million	-15,736 Reduced 6.71%	218,819 $63.5 Million
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $2.37 Million - $3.36 Million	-9,129 Reduced 3.75%	234,555 $64.2 Million
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $3.58 Million - $4.01 Million	11,623 Added 5.01%	243,684 $77.6 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $65.2 Million - $76.5 Million	232,061	232,061 $72.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.

Account

Amf Tjanstepension Ab Biogen Inc. Transaction History